TruthArchive.ai - Related Video Feed

This video discusses research by virologist Luc Montagnier showing HIV RNA fragments in the spike protein. Montagnier, known for identifying HIV, found 18 RNA fragments matching HIV and SIV in the spike protein. The presence of these fragments raises questions about the origins of the virus. The video highlights the complexity of the situation and the need for further investigation.

Bonjour à tous, Anaïs Bloqué, docteur en biologie santé, explique les impacts de la protéine Spike du SARS-CoV-2 sur le système immunitaire inné, basés sur son article récent. La Spike seule n'active pas complètement le TLR 4, un récepteur immunitaire, et ne permet pas la production d'interférons de type 1, essentiels pour lutter contre le virus. Pour une activation complète, la Spike doit s'associer au LPS (des bactéries gram négatifs). L'activation des interférons 1 augmente l'expression d'ACE2, le récepteur du virus, sensibilisant l'organisme à l'infection. Les interférons 1 peuvent aussi être activés par les RLR, notamment MDA5, qui détecte l'ARN messager modifié des vaccins anti-COVID. De plus, la Spike, protéine amyloïde, peut déclencher le TLR 4 en s'associant aux fibres amyloïdes A bêta 42, créant un "double effet amyloïde". L'augmentation de NF-κB par les interférons 1 peut bloquer la p53, un suppresseur de tumeur, et induire l'expression du MIR-29b, qui bloque ACE2. Chez les personnes avec comorbidités, ayant déjà de faibles niveaux d'ACE2, cette interaction Spike-LPS devient dangereuse, créant une boucle d'amplification inflammatoire. La Spike persiste longtemps dans l'organisme, et avec ses propriétés amyloïdes, pourrait entraîner des pathologies dégénératives à long terme. --- Hello everyone, Anaïs Bloqué, Doctor of Philosophy in Health Biology, explains the impacts of the SARS-CoV-2 Spike protein on the innate immune system, based on her recent article. The Spike alone does not fully activate TLR 4, an immune receptor, and does not allow the production of type 1 interferons, which are essential for fighting the virus. For complete activation, the Spike must associate with LPS (from gram-negative bacteria). Activation of interferon 1 increases the expression of ACE2, the virus's receptor, sensitizing the body to infection. Interferons 1 can also be activated by RLRs, in particular MDA5, which detects the modified messenger RNA of anti-COVID vaccines. In addition, Spike, an amyloid protein, can trigger TLR 4 by associating with amyloid A beta 42 fibers, creating a "double amyloid effect". The increase in NF-κB by interferons 1 can block p53, a tumor suppressor, and induce the expression of MIR-29b, which blocks ACE2. In people with comorbidities, who already have low levels of ACE2, this Spike-LPS interaction becomes dangerous, creating an inflammatory amplification loop. Spike persists in the body for a long time, and with its amyloid properties, could lead to long-term degenerative pathologies.

I contracted SARS in South Korea during the outbreak. It caused neurological symptoms and was different from the flu or norovirus. I couldn't get a proper diagnosis, but I realized it was serious when I saw what was happening in Wuhan. There was an effort to suppress information beyond the official narrative. I believed it came from a lab and published a paper on it. I've been trying to inform people about the role of viruses in chronic neurodegenerative diseases. The spike protein in the virus can misfold and cause amyloidosis. There are safety concerns with gene transfection, and we're seeing excess deaths, especially in dementia cases. Synthetic peptides may be a contributing factor.

In this video, the speaker discusses the presence of white fibrous clots in bodies. They conducted a survey last year to determine if this phenomenon was real. The survey revealed that around 70% of embalmers were seeing these clots, with most of them noticing them after the rollout of vaccines in 2021. Some embalmers reported seeing these clots in up to 50% or more of the corpses they worked with. The speaker is currently conducting another survey to gather more information on what embalmers are observing in 2023.

Tom Haviland, a retired major in the US Air Force and an experienced embalmer, discusses the presence of white fibrous clots found in the circulatory systems of deceased individuals. These clots, which have been observed in a high percentage of corpses over the past three years, are believed to be made of amyloid protein and fibrin. Embalmers have noticed an increase in the size and prevalence of these clots, as well as an increase in microclotting or "coffee ground" clots. The data collected from embalmers suggests that these clots may be linked to the spike protein produced by the COVID-19 vaccines.

The clots being formed, we've run mass spectrometry on these clots. They don't look like normal clots. They don't have the same composition. They don't have fibrin. They don't have thrombin, which are normal things you would see in a normal coagulation cascade. They have, instead, all the fibrinogen chains—alpha, beta, and gamma. They have them in a strange differential where it's not one-to-one-to-one; it's about 36 to 16 to 4 by ratios. They're aberrantly cross-linked by sulfide bonds. There's a ton of tin for some reason. I don't know why there's tin in there, but there's a ton of tin in there and a ton of phosphorus. And the spike protein is actually coated in GLIKNAK, which is a phosphate donor. So that might explain all the phosphorus if it's providing the energetics or in some way by cleaving or creating phosphate bonds. So I think that that's a big problem because that's a slow progression of coagulopathy that's, I think, narrowing the lumens of the vascular system, which is contributing to some of the organ failure that we're seeing, some of the neurological symptomatology that we're seeing, some of the fatigue, and things of that nature. And then finally, the spike protein is shown to produce—it’s shown to induce misfolding of proteins and actually

The speaker discusses how the spike protein in vaccines can lead to clotting issues, immune suppression, and reactivation of latent viruses like mono. This can also weaken the body's ability to fight off other viruses and cancers. An increase in cancer cases post-vaccination is noted anecdotally. The speaker attributes these effects to the spike protein in the vaccines.

The speaker is frustrated because they received an important video that they can't share due to it being blocked on various platforms. They then introduce another speaker who discusses the concerns about aluminum nanoparticles in vaccines. The speaker explains that these nanoparticles can enter the brain and potentially cause neurodevelopmental disabilities, including Alzheimer's. They argue that the safety of aluminum nanoparticles in vaccines has not been properly evaluated and that vaccine ingredients can enter the brain. The speaker also mentions the link between vaccines and chronic inflammation, as well as the rise in neurodevelopmental disabilities, autoimmune diseases, and seizures. They conclude by stating that vaccines have not been effectively studied and are not as safe as claimed.

The speaker discusses the harmful effects of the spike protein found in COVID-19 vaccines. They mention a study showing that almost a third of patients experienced neurological issues from the spike protein. They express concern about the lack of an off switch for this gene and the potential for autoimmune and neurological harm. The speaker also addresses criticism of fearmongering and highlights the connection between the spike protein and HIV. They mention studies linking COVID-19 vaccines to autism in rats and discuss the use of edible vaccines in plants. The speaker emphasizes the importance of sharing information and concludes by promoting their video game.

In a deceased patient, spike protein was found in the heart but not nucleocapsid protein. The autopsy revealed bronchopneumonia, Parkinson's disease, necrotic encephalitis, and myocarditis. The author suggests that the spike protein in affected tissues was likely from gene-based COVID-19 vaccines, not a SARS CoV-2 infection, as nucleocapsid protein was absent. Spike protein was found in areas with brain and heart inflammation, possibly contributing to the disease.

**French Summary:** Anaïs Bloqué explique l'impact de la protéine Spike du SARS-CoV-2 sur le système immunitaire inné, en se concentrant sur le TLR 4. La Spike seule n'active pas complètement le TLR 4 pour induire une réponse antivirale complète (interférons de type 1). L'association Spike-LPS (lipopolysaccharide bactérien) est nécessaire. L'activation des interférons 1 augmente l'expression d'ACE2, récepteur du virus, via les ISG, sensibilisant l'organisme à l'infection. Les ARN messagers des vaccins peuvent aussi activer les interférons 1 via MDA5. La Spike, protéine amyloïde, peut induire la production de fibres A bêta 42, aggravant l'inflammation. L'augmentation de NF-κB par les ISG peut bloquer p53 (suppresseur de tumeur) et induire le micro-ARN MIR-200c, diminuant l'expression d'ACE2. Chez les personnes avec comorbidités (diabète, obésité), une boucle d'amplification inflammatoire Spike-LPS-TLR4 réduit l'ACE2 disponible, menant à une suractivation de l'angiotensine 2. La Spike persistante pourrait causer des pathologies dégénératives à long terme. **English Translation:** Anaïs Bloqué explains the impact of the SARS-CoV-2 Spike protein on the innate immune system, focusing on TLR 4. Spike alone does not fully activate TLR 4 to induce a complete antiviral response (type 1 interferons). The Spike-LPS (bacterial lipopolysaccharide) association is necessary. Activation of interferon 1 increases ACE2 expression, the virus receptor, via ISGs, sensitizing the body to infection. Vaccine mRNAs can also activate interferon 1 via MDA5. Spike, an amyloid protein, can induce the production of A beta 42 fibers, worsening inflammation. Increased NF-κB by ISGs can block p53 (tumor suppressor) and induce microRNA MIR-200c, decreasing ACE2 expression. In people with comorbidities (diabetes, obesity), a Spike-LPS-TLR4 inflammatory amplification loop reduces available ACE2, leading to overactivation of angiotensin 2. Persistent Spike could cause long-term degenerative pathologies.

The speaker discusses issues with RNA vaccines, such as frame shifting and template switching, potentially leading to the production of abnormal proteins. They highlight concerns about mitochondrial sequences in vaccines causing adverse effects in patients. The conversation delves into the risks of amyloidogenic proteins and their ability to trigger a chain reaction of misfolding, leading to serious health implications. The speaker emphasizes the need for further research and vigilance in monitoring potential risks associated with RNA vaccines.

Protein misfolding is a recent phenomenon in the study of neurodegenerative disorders like Parkinson's and Alzheimer's. Other peptides besides the prion protein can also misfold and form toxic fibrils. Prions have been studied as potential biological warfare agents due to their robustness and toxicity. The transmission of prions is difficult, but recent research suggests that small epitopes on viruses and bacteria may also have amyloidogenic properties. Neuroinvasion and anosmia are independent phenomena caused by SARS-CoV-2 infection, indicating ongoing pathology at a fundamental level. The spike protein of SARS-CoV-2 has been found to cause amyloidogenic clots in the blood, potentially contributing to long-haul symptoms. There are also concerns about the homology between SARS-CoV-2 and HIV, as HIV epitopes have amyloidogenic properties and have been the focus of bioweapon research.

The spike protein, according to research in South Africa, induces fibrin from fibrinogen, forming the backbone of clotting in a way not previously seen. Unlike normal fibrin clots that are easily broken down, clots formed from COVID or the spike protein from the vaccine are difficult to break down, causing issues for many people. A cardiologist stated that in their decades of practice, they have never treated as many blood clots as in the last five years. These blood clots occur after the virus infection and the vaccine because the spike protein causes blood clots. Therefore, it is reckless to continue vaccinating people and loading the body with spike protein, causing more blood clots. According to a paper in Cell (July 2021), the nucleoprotein, not the spike protein, supplied broad and durable immunity for the prevention of infection. The speaker questions why the vaccine wasn't changed to target the nucleoprotein once this information came to light.

Spike is a toxin that can cross the blood-brain barrier, causing disruption to the brain's blood vessels and leading to inflammation. This inflammation is responsible for the brain fog experienced by both COVID patients and those who have been vaccinated. Despite claims that there have been no deaths or injuries from the vaccine, this is not true. The image shown reveals the presence of inflammation in the brain, indicated by the blue color. This inflammation is a result of the spike toxin.

The speaker discusses the inflammatory and amyloidogenic effects of small sequences called epitopes, which can cause memory dysfunction in mice. They also mention a study that found the introduction of gene transfection technologies containing the spike protein can induce amyloidogenic cascades. The speaker highlights a 200% increase in the diagnosis of CJD in France after the rollout of vaccination programs, suggesting a potential link. They discuss the loss of cognitive function associated with exposure to the spike protein and propose that amyloidogenic disease processes may underlie long-haul COVID-19 symptoms. The speaker mentions the role of viral infections in facilitating intercellular aggregate dissemination and shares examples of misfolding prion amyloidogenic diseases.

This video discusses concerns about informed consent and the presence of SV40 promoters in Pfizer vaccines. The speaker mentions Kevin McKernan's findings of plasmid DNA in the vials. Legal proceedings in Australia are mentioned, questioning the classification of these vaccine products. The speaker also talks about amyloidogenic sequences associated with viruses and their presence in SARS-CoV-2. They discuss a study on amyloidogenesis of the spike protein and how it could trigger amyloidogenic aggregation. The speaker highlights the increased attractiveness of the spike protein to neutrophil elastase due to added amino acids. They mention an analysis that shows similarities in amyloidogenic properties between the natural virus spike protein and the one translated in vaccine recipients. The video concludes with a mention of the cleavage of the spike protein and its potential implications.

White fibrous clots found in the living and dead recipients of mRNA vaccines are being ignored, but research reveals their composition and cause. The spike protein mutates fibrin into jagged, misfolded, insoluble amyloid, similar to prionic infections. Microclots form and align into large white clots, initiated by spike protein fragments like spike 601. Prolene, a "kinker protein" added to the spike protein, causes misfolding, with proline being prevalent in the clots. A 2021 paper showed the SARS CoV-2 spike induces abnormal blood clots due to the fibrinogen beta chain. Plasma exposed to the spike protein is imbalanced, with the fibrinogen beta chain being dominant. These clots contain four times the normal amount of phosphorus, released from lipid nanoparticles. Similar clots in 1988 were caused by sulfur-based heparin, which was resolved by reducing sulfur content. A 2017 paper showed altered phosphorus levels cause cancer. Thomas Havilland, who shares this information, is being ignored by mainstream and alternative media. Undertakers are seeing massive white fibrous clots at record levels.

The speaker discusses various topics including the need for research in gain of function for Freon Science, the possibility of iron dysregulation causing neurodegenerative states, and the difficulty in treating amyloidogenic peptides. They also mention a research accident in Guangzhou, China that may have released a cancer-causing virus. The speaker expresses suspicion towards research programs in certain countries and urges caution in believing their claims of innocence. They thank some individuals for their support and apologize for technical difficulties. The speaker concludes by emphasizing the challenges of breaking down amyloids and prions through autophagy and encourages sharing the lecture to spread awareness.

The speaker discusses the formation of clots induced by the spike protein in the blood. These clots can be white and fibrous, and they can vary in size. The speaker mentions that these clots can lead to heart attacks or strokes if they block the flow of oxygen in the body. They also mention an enzyme called Nattokinase, derived from fermented soy, which can break down fibrin and dissolve clots. The speaker suggests that using enzymatic mechanisms to break down clots early can prevent the accumulation of amyloid proteins and the worsening of clots.

The spike protein from the COVID-19 virus circulates in the body and can land in multiple organs, causing various diseases. Lab studies have shown that even without the virus, just injecting the spike protein can induce the same lung, vascular, heart, and brain diseases as COVID-19. The spike protein is considered the toxin responsible for causing the disease. This raises questions about why we are injecting something that is essentially a toxin into the human body, as it is not a traditional vaccine.

Speaker 0 asserts that truth is out and that scientists are now confirming long-suspected effects of the COVID-19 shots beyond the immune system, specifically that they can damage the brain and devastate mental health. The claim is that the evidence is overwhelming and that a new wave of studies has revealed significant increases in various neurological and psychiatric conditions, all linked to the presence of toxic spike protein accumulation and persistence in the brain. The summary of claimed study findings includes: - Ischemic strokes: up forty-four percent. - Hemorrhagic strokes: up fifty percent. - Transient ischemic strokes (mini strokes): up sixty-seven percent. - Myasthenia gravis, described as a debilitating autoimmune condition: up over seventy-one percent. - Alzheimer’s disease: up twenty-two percent. - Cognitive impairment: up nearly one hundred and thirty-eight percent. - Depression: up over sixty-eight percent. - Anxiety disorders: up nearly forty-four percent. - Sleep disorders: up over ninety-three percent. Speaker 0 links all of these increases to one cause: toxic spike protein accumulation and persistence in the brain. The statement "This isn't a conspiracy theory" is used to bolster the claim that there is documented peer-reviewed research and published studies supporting these observations. The speaker cites epidemiologist Nicholas Holcher as an example of an expert who has commented on the issue. The quote attributed to Holcher describes using mRNA to hijack cells in various organ systems to produce a highly toxic spike protein that persists in the body for months or even years, and characterizes this approach as one of the worst ideas in medical history. In closing, Speaker 0 poses a question, "So what can you do?" signaling a transition from presenting the alleged findings to offering potential actions or recommendations. The overall message is that COVID-19 vaccines are claimed to cause widespread brain toxicity and mental health problems through persistent spike protein, with purported evidence from peer-reviewed studies and expert commentary cited to support the assertions.

Bonjour à tous, Anaïs Bloqué, docteur en biologie santé, explique les impacts de la protéine Spike du SARS-CoV-2 sur le système immunitaire inné, basés sur son article récent. La Spike seule n'active pas complètement le TLR 4, un récepteur immunitaire, et ne produit pas d'interférons de type 1, essentiels pour la réponse antivirale. Pour une activation complète, la Spike doit s'associer au LPS (des bactéries Gram négatif). L'activation des interférons 1 augmente l'expression d'ACE2, le récepteur du virus, via les ISG, sensibilisant l'organisme à l'infection. Les ARN messagers des vaccins peuvent aussi lancer la production d'interférons 1 via MDA5. La Spike, protéine amyloïde, peut aussi déclencher le TLR 4 avec des fibres amyloïdes, entraînant un "double effet amyloïde". L'augmentation de NF-κB par les ISG peut bloquer la p53, potentiellement cancérigène. De plus, NF-κB induit le MIR-200c, qui bloque l'ACE2. Chez les individus avec comorbidités, une boucle d'amplification inflammatoire se crée : Spike-LPS-TLR4 induit interférons 1, ISG, surexpression d'ACE2, augmentation de NF-κB, MIR-200c, diminution d'ACE2 et augmentation d'angiotensine 2. La Spike persiste longtemps, et ses propriétés amyloïdes font craindre des pathologies dégénératives à long terme. --- Hello everyone, Anaïs Bloqué, PhD in health biology, explains the impacts of the SARS-CoV-2 Spike protein on the innate immune system, based on her recent article. Spike alone does not fully activate TLR 4, an immune receptor, and does not produce type 1 interferons, which are essential for the antiviral response. For complete activation, Spike must associate with LPS (from Gram-negative bacteria). Activation of interferon 1 increases the expression of ACE2, the virus's receptor, via ISGs, sensitizing the body to infection. Vaccine mRNAs can also trigger the production of interferon 1 via MDA5. Spike, an amyloid protein, can also trigger TLR 4 with amyloid fibers, leading to a "double amyloid effect." The increase in NF-κB by ISGs can block p53, which is potentially carcinogenic. In addition, NF-κB induces MIR-200c, which blocks ACE2. In individuals with comorbidities, an inflammatory amplification loop is created: Spike-LPS-TLR4 induces interferon 1, ISG, ACE2 overexpression, increased NF-κB, MIR-200c, decreased ACE2 and increased angiotensin 2. Spike persists for a long time, and its amyloid properties raise concerns about long-term degenerative pathologies.

The speaker believes mRNA vaccines are producing an abnormal spike protein that doesn't enter the membrane, potentially leading to prion problems. Prion proteins misfold into beta sheets in the cytoplasm, forming crystals that attract other proteins and create fibrils like Alzheimer's plaque. The speaker claims the vaccines produce many spike proteins that cannot enter the membrane, increasing the likelihood of becoming problematic prion proteins. This is described as a setup for Parkinson's disease, potentially causing earlier onset or new cases in vaccinated individuals. The speaker suggests annual boosters may accelerate the development of Parkinson's.

In this video, the speaker discusses some findings from their investigations into COVID-19 vaccines. They mention a sample that showed no phosphorus, which could be experimental error. They also found small specks of copper in some vaccines, but the reason for this is unknown. The speaker then talks about their own experiment where they added the Pfizer vaccine to blood and observed discoloration and clumping of red blood cells. They suggest that this could be due to the cationic lipid in the vaccine coming into contact with cell membranes. They emphasize the importance of informed consent and the need for more research on these vaccine effects.